Publications: Ms Julia Gutjahr
Gutjahr JC, Rot A
(
2022
)
.
New unexpected role of CXCL12-CXCR4 signalling in erythropoiesis
.
EUROPEAN JOURNAL OF IMMUNOLOGY
.
vol.
52
,
63
-
64
.
Rot A, Gutjahr JC, Biswas A, Aslani M, Hub E, Thiriot A, von Andrian UH, Megens RTA et al.
(
2022
)
.
Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
.
Cell Stem Cell
vol.
29
,
(
7
)
1013
-
1015
.
Yu X, Munoz-Sagredo L, Streule K, Muschong P, Bayer E, Walter RJ, Gutjahr JC, Greil R et al.
(
2021
)
.
CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues
.
Blood
vol.
138
,
(
12
)
1067
-
1080
.
Gutjahr JC, Crawford KS, Jensen DR, Naik P, Peterson FC, Samson GPB, Legler DF, Duchene J et al.
(
2021
)
.
The dimeric form of CXCL12 binds to atypical chemokine receptor 1
.
Science Signaling
vol.
14
,
(
696
)
eabc9012
-
eabc9012
.
Gutjahr JC, Bayer E, Yu X, Laufer JM, Höpner JP, Tesanovic S, Härzschel A, Auer G et al.
(
2021
)
.
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
.
Haematologica
vol.
106
,
(
8
)
2102
-
2113
.
Werth K, Hub E, Gutjahr JC, Bosjnak B, Zheng X, Bubke A, Russo S, Rot A et al.
(
2021
)
.
Expression of ACKR4 demarcates the “peri-marginal sinus,” a specialized vascular compartment of the splenic red pulp
.
Cell Reports
vol.
36
,
(
2
)
Crawford K, Gutjahr J, Rot A, Volkman B
(
2021
)
.
Dimeric CXCL12 (SDF‐1) binds to atypical chemokine receptor 1 (ACKR1/DARC)
.
The FASEB Journal
.
vol.
35
,
Szenes E, Härzschel A, Decker S, Tissino E, Pischeli J, Gutjahr JC, Kissel S, Pennisi S et al.
(
2020
)
.
TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
.
Leukemia
vol.
34
,
(
9
)
2498
-
2502
.
Gutjahr JC, Szenes E, Tschech L, Asslaber D, Schlederer M, Roos S, Yu X, Girbl T et al.
(
2018
)
.
Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia
.
Blood
vol.
131
,
(
12
)
1337
-
1349
.
Tissino E, Benedetti D, Herman SEM, ten Hacken E, Ahn IE, Chaffee KG, Rossi FM, Bo MD et al.
(
2018
)
.
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
.
Journal of Experimental Medicine
vol.
215
,
(
2
)
681
-
697
.
Catakovic K, Gassner FJ, Ratswohl C, Zaborsky N, Rebhandl S, Schubert M, Steiner M, Gutjahr JC et al.
(
2018
)
.
TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia
.
OncoImmunology
vol.
7
,
(
1
)
Roos S, Schlederer M, Hartmann T, Gutjahr JC, Szenes E, Tschech L, Girbl T, Greil R et al.
(
2017
)
.
CLL cells residing in spleen and bone marrow microenvironments differ in their CD44 variant usage for migration and proliferation
.
LEUKEMIA & LYMPHOMA
.
vol.
58
,
41
-
42
.
Tissino E, Benedetti D, Herman SE, ten Hacken E, Ahn IE, Chaffee KG, Rossi FM, Dal Bo M et al.
(
2017
)
.
INSIDE-OUT VLA-4 INTEGRIN ACTIVATION IS MAINTAINED IN IBRUTINIB-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA EXPRESSING CD49D: CLINICAL RELEVANCE
.
HAEMATOLOGICA
.
vol.
102
,
229
-
229
.
Ganghammer S, Gutjahr J, Hutterer E, Krenn PW, Pucher S, Zelle-Rieser C, Jöhrer K, Wijtmans M et al.
(
2016
)
.
Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors
.
Haematologica
vol.
101
,
(
3
)
e99
-
e102
.
Gutjahr JC, Greil R, Hartmann TN
(
2015
)
.
The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
.
Frontiers in Immunology
vol.
6
,
(
MAR
)